Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
about
The Diagnostic Performance of Stool DNA Testing for Colorectal Cancer: A Systematic Review and Meta-AnalysisFecal DNA testing for colorectal cancer screening: Molecular targets and perspectivesCell-free nucleic acids as noninvasive biomarkers for colorectal cancer detectionUse of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer ScreeningIdentification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics dataAberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancerAnalysis of DNA Methylation Status in Bodily Fluids for Early Detection of CancerColorectal cancer: from prevention to personalized medicine.Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancerDiagnostic value of stool DNA testing for multiple markers of colorectal cancer and advanced adenoma: a meta-analysisPromoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer.Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.Fecal molecular markers for colorectal cancer screeningEpigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancerNovel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.Methylation-mediated loss of SFRP2 enhances melanoma cell invasion via Wnt signaling.Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model.Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening.Advances in epigenetic biomarker research in colorectal cancerp33(ING1b) methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.DNA methylation assay for colorectal carcinomaPromoter CpG island methylation markers in colorectal cancer: the road ahead.Epigenetic biomarkers in colorectal cancer diagnostics.Noninvasive screening tests for colorectal cancer.DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.New molecular diagnosis and screening methods for colorectal cancer using fecal protein, DNA and RNA.Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.Early detection of colorectal cancer: from conventional methods to novel biomarkers.Bisulfite-Based DNA Methylation Analysis from Recent and Archived Formalin-Fixed, Paraffin Embedded Colorectal Tissue Samples.Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review.Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion.A pan-cancer analysis of secreted Frizzled-related proteins: re-examining their proposed tumour suppressive function.Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease.Comparison of Automated and Manual DNA Isolation Methods for DNA Methylation Analysis of Biopsy, Fresh Frozen, and Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Samples.Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection.Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer.
P2860
Q26769039-7F8E728F-6DCD-46E5-A8B7-993795DF95FBQ26781466-DAB6F968-96AA-4410-92CE-937B710AC8ABQ26991998-744A804C-96FA-4290-B49E-BA3BEC7D9D7AQ30243864-130E0530-CD1B-43EB-9CB3-3FC60BA8A9D7Q30956148-309C4666-633A-4ED7-A796-75A55D852D1BQ33596504-F19BB809-25AA-42BB-AB90-FF07F0B63DFAQ33624423-CA3EE168-A7BC-4667-9F4D-80D6FEA2212BQ33735234-810EBA23-46B5-4383-86D1-A89D9213B0DEQ34487177-198CF549-1045-406C-A8D3-CF8740DAF005Q34706624-B40B1A08-4DCA-4D74-A956-DED7C578DA53Q34927685-0FDBB2F0-63CD-4B7D-9B65-FB100A3977B3Q35138892-C014E9CA-BD25-492E-A96D-79B7292A1207Q35194198-EC4B52F0-CD0E-44E6-BAB8-74D24496A8CCQ35579457-381101E2-9683-4655-A9F3-D018DBA1FB3EQ35759614-B6A0FDB1-4FCE-4DF8-B95E-C5626B013475Q35813626-A1866225-1E34-455A-ABB0-A91B17A3014CQ36296760-9E54F414-7509-44FF-876B-3A5EEBFD401DQ36878593-1AA72472-273D-4717-B37A-BFA1D92227CFQ37225891-19E742A1-FF3B-4036-A754-45500A1C854CQ37346216-300945A1-2D2A-4959-A9FE-88E09FBBA069Q37536997-51A1F8CE-039C-4901-961A-AEAC52A43B3FQ37708022-74A5E41B-9D58-469D-A31B-C39D9AF6AFE6Q37719946-33D5F8B6-0213-48AF-8846-B9C63605B532Q37720420-02673E4A-5111-4EEA-9381-63FD68FCFB8DQ37997086-0B34EE71-F4F6-4D66-A15F-4BAEEEE55526Q38018997-8B5BA73C-3449-47B5-9E52-092C8CCB847FQ38064739-74A29480-8F23-4D07-8C0A-BD17668DF9DCQ38140769-C760BEE2-79C3-44C4-9E41-CE4CF7B9C105Q38168867-995AAAAA-3C74-4163-948A-14572027E788Q38260688-576D47D4-B3AC-4934-BA14-73262E5A2FC9Q38357717-9E06BB27-1C2B-4E90-A2B2-729F7CA8E5EAQ38386231-2D67BD1F-41AD-4ED3-B8DA-690410EE3C1FQ38632658-83550F5C-BF2E-4DC3-A06A-6AD246D9C4FEQ38783017-A6FD8B90-8A67-4EBA-A5A5-A5885AF65846Q38815109-3AA7B1ED-818F-42B5-B62E-ABA876AD1D12Q38952038-51264387-02E2-4FC7-AC28-55BF153C9819Q41465832-4AF993FB-5187-4891-BF14-66596E0CF73CQ42175301-AC76F7D1-6803-4A86-8534-6865FD3D6C58Q46827905-293BC1B1-0BEE-47DB-B109-5C3F0BE833B6Q47132498-2719DE2A-F8E8-4624-951C-149F947D63FD
P2860
Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypermethylated SFRP2 gene in ...... cancer noninvasive screening.
@en
Hypermethylated SFRP2 gene in ...... cancer noninvasive screening.
@nl
type
label
Hypermethylated SFRP2 gene in ...... cancer noninvasive screening.
@en
Hypermethylated SFRP2 gene in ...... cancer noninvasive screening.
@nl
prefLabel
Hypermethylated SFRP2 gene in ...... cancer noninvasive screening.
@en
Hypermethylated SFRP2 gene in ...... cancer noninvasive screening.
@nl
P2860
P921
P356
P1476
Hypermethylated SFRP2 gene in ...... cancer noninvasive screening.
@en
P2093
Dao-Rong Wang
P2860
P304
P356
10.3748/WJG.14.524
P407
P577
2008-01-01T00:00:00Z